UBS Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.88M | Sell |
65,865
-38,195
| -37% | -$1.3M | ﹤0.01% | 5030 |
|
|
2025
Q4 | $4.12M | Buy |
104,060
+11,401
| +12% | +$418K | ﹤0.01% | 4222 |
|
|
2025
Q3 | $3.27M | Sell |
92,659
-23,497
| -20% | -$810K | ﹤0.01% | 4473 |
|
|
2025
Q2 | $3.81M | Buy |
116,156
+13,129
| +13% | +$427K | ﹤0.01% | 4155 |
|
|
2025
Q1 | $3.32M | Sell |
103,027
-41,153
| -29% | -$1.53M | ﹤0.01% | 4214 |
|
|
2024
Q4 | $4.41M | Buy |
144,180
+99,635
| +224% | +$3.2M | ﹤0.01% | 3970 |
|
|
2024
Q3 | $1.25M | Sell |
44,545
-36,804
| -45% | -$907K | ﹤0.01% | 4445 |
|
|
2024
Q2 | $1.85M | Buy |
81,349
+9,256
| +13% | +$214K | ﹤0.01% | 3843 |
|
|
2024
Q1 | $2.19M | Buy |
72,093
+5,532
| +8% | +$185K | ﹤0.01% | 3855 |
|
|
2023
Q4 | $2.38M | Buy |
66,561
+34,367
| +107% | +$1.28M | ﹤0.01% | 3626 |
|
|
2023
Q3 | $1.41M | Sell |
32,194
-1,122
| -3% | -$54.7K | ﹤0.01% | 3786 |
|
|
2023
Q2 | $1.64M | Buy |
33,316
+11,236
| +51% | +$518K | ﹤0.01% | 3720 |
|
|
2023
Q1 | $915K | Buy |
22,080
+9,441
| +75% | +$392K | ﹤0.01% | 4198 |
|
|
2022
Q4 | $561K | Buy |
12,639
+6,756
| +115% | +$282K | ﹤0.01% | 4607 |
|
|
2022
Q3 | $230K | Buy |
5,883
+2,735
| +87% | +$125K | ﹤0.01% | 4962 |
|
|
2022
Q2 | $129K | Buy |
3,148
+1,732
| +122% | +$82K | ﹤0.01% | 5227 |
|
|
2022
Q1 | $93K | Sell |
1,416
-6,241
| -82% | -$404K | ﹤0.01% | 5981 |
|
|
2021
Q4 | $532K | Buy |
7,657
+5,938
| +345% | +$432K | ﹤0.01% | 4930 |
|
|
2021
Q3 | $120K | Sell |
1,719
-3,088
| -64% | -$238K | ﹤0.01% | 5695 |
|
|
2021
Q2 | $382K | Buy |
4,807
+884
| +23% | +$64.3K | ﹤0.01% | 4916 |
|
|
2021
Q1 | $257K | Sell |
3,923
-2,389
| -38% | -$147K | ﹤0.01% | 5302 |
|
|
2020
Q4 | $351K | Buy |
+6,312
| New | +$273K | ﹤0.01% | 4860 |
|
|
2020
Q3 | – | Sell |
-144
| Closed | -$6K | – | 7965 |
|
|
2020
Q2 | $6K | Sell |
144
-69
| -32% | -$3K | ﹤0.01% | 7280 |
|
|
2020
Q1 | $7K | Sell |
213
-1,002
| -82% | -$36K | ﹤0.01% | 7126 |
|
|
2019
Q4 | $40K | Buy |
1,215
+520
| +75% | +$14.8K | ﹤0.01% | 6473 |
|
|
2019
Q3 | $17K | Sell |
695
-5,949
| -90% | -$170K | ﹤0.01% | 6822 |
|
|
2019
Q2 | $199K | Buy |
6,644
+6,412
| +2,764% | +$187K | ﹤0.01% | 4917 |
|
|
2019
Q1 | $6K | Sell |
232
-18,662
| -99% | -$567K | ﹤0.01% | 7066 |
|
|
2018
Q4 | $578K | Buy |
18,894
+8,967
| +90% | +$279K | ﹤0.01% | 4156 |
|
|
2018
Q3 | $348K | Buy |
9,927
+5,301
| +115% | +$168K | ﹤0.01% | 4655 |
|
|
2018
Q2 | $125K | Buy |
4,626
+3,209
| +226% | +$75.4K | ﹤0.01% | 5284 |
|
|
2018
Q1 | $29K | Sell |
1,417
-431
| -23% | -$7.78K | ﹤0.01% | 6104 |
|
|
2017
Q4 | $34K | Sell |
1,848
-125
| -6% | -$2.48K | ﹤0.01% | 6136 |
|
|
2017
Q3 | $44K | Buy |
1,973
+137
| +7% | +$3.1K | ﹤0.01% | 5874 |
|
|
2017
Q2 | $45K | Buy |
1,836
+103
| +6% | +$2.19K | ﹤0.01% | 5728 |
|
|
2017
Q1 | $33K | Sell |
1,733
-25,165
| -94% | -$441K | ﹤0.01% | 5779 |
|
|
2016
Q4 | $526K | Buy |
26,898
+2,417
| +10% | +$43.8K | ﹤0.01% | 4073 |
|
|
2016
Q3 | $387K | Sell |
24,481
-1,712
| -7% | -$26.3K | ﹤0.01% | 4085 |
|
|
2016
Q2 | $370K | Sell |
26,193
-192
| -0.7% | -$2.93K | ﹤0.01% | 4125 |
|
|
2016
Q1 | $444K | Sell |
26,385
-1,048
| -4% | -$18.4K | ﹤0.01% | 3865 |
|
|
2015
Q4 | $615K | Buy |
27,433
+689
| +3% | +$14.2K | ﹤0.01% | 3785 |
|
|
2015
Q3 | $586K | Buy |
26,744
+1,817
| +7% | +$45.4K | ﹤0.01% | 3766 |
|
|
2015
Q2 | $614K | Buy |
24,927
+1,025
| +4% | +$22.9K | ﹤0.01% | 3943 |
|
|
2015
Q1 | $489K | Buy |
23,902
+21,683
| +977% | +$420K | ﹤0.01% | 4170 |
|
|
2014
Q4 | $44K | Buy |
+2,219
| New | +$38.1K | ﹤0.01% | 6646 |
|
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
